fulvestrant has been researched along with Peripheral Nerve Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caaveiro, JMM; Egashira, N; Ito, M; Tozaki-Saitoh, H; Tsuda, M; Yamamoto, S; Yamashita, T | 1 |
| Andersen, CB; Brann, MR; Cheevers, C; Del Tredici, AL; Donello, JE; Fairbairn, LC; Gardell, LR; Gil, DW; Gustafsson, M; Hyldtoft, L; Lund, BW; Olsson, R; Piu, F; Schiffer, HH | 1 |
2 other study(ies) available for fulvestrant and Peripheral Nerve Diseases
| Article | Year |
|---|---|
New pharmacological effect of fulvestrant to prevent oxaliplatin-induced neurodegeneration and mechanical allodynia in rats.
Topics: Animals; Cell Line; Fulvestrant; Hybridomas; Hyperalgesia; Male; Mice; Neurons; Neuroprotective Agents; Oxaliplatin; Peripheral Nervous System Diseases; Rats, Sprague-Dawley | 2019 |
Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor beta; Female; Fulvestrant; Humans; Male; Mice; Mice, Inbred BALB C; Pain; Pain Threshold; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Uterus | 2008 |